Enhancing Treatment Outcomes for Depression: From Guidelines to Biomarkers
Date(s) - 24/02/2017
12:00 pm - 1:00 pm
Baycrest - Classroom ABC
Sidney H. Kennedy, MD, FRCPC, FCAHS
Arthur Sommer Rotenberg Chair in Suicide and Depression Studies, St. Michael’s Hospital
Professor, Department of Psychiatry, University of Toronto
Principal Investigator, Canadian Biomarker Integration Network in Depression (CAN-BIND)
Scientist, Li Ka Shing Knowledge Institute
Senior Scientist, Krembil Research Institute
By the end of the session, participants will be able to:
- Appreciate the range of pharmacological and neurostimulation options for treatment resistant depression.
- Understand the potential of neuroimaging and molecular biomarkers to predict antidepressant response.
- Recognize the complexities of integrating clinical and biological big data.
Also available via Telehealth & Webcast.
To participate Through Telehealth:
Provide your Telehealth Coordinator TSM # 65167360 to confirm your site
To Participate by Live Webcast:
Search for Baycrest or TSM # 65167360 under live “public” events on http://webcast.otn.ca
Accredited (group learning) as defined by the Maintenance of Certification Program of the RCPS.
*Rounds are restricted to Baycrest healthcare professionals in active practice, students and staff.